DK145339C - Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf

Info

Publication number
DK145339C
DK145339C DK31476A DK31476A DK145339C DK 145339 C DK145339 C DK 145339C DK 31476 A DK31476 A DK 31476A DK 31476 A DK31476 A DK 31476A DK 145339 C DK145339 C DK 145339C
Authority
DK
Denmark
Prior art keywords
analogue
amino
preparation
acceptable salts
pharmaceutical acceptable
Prior art date
Application number
DK31476A
Other languages
Danish (da)
English (en)
Other versions
DK145339B (da
DK31476A (da
Inventor
B W Metcalf
M Jung
Original Assignee
Merrell Toraude & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Toraude & Co filed Critical Merrell Toraude & Co
Publication of DK31476A publication Critical patent/DK31476A/da
Publication of DK145339B publication Critical patent/DK145339B/da
Application granted granted Critical
Publication of DK145339C publication Critical patent/DK145339C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK31476A 1975-03-18 1976-01-27 Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf DK145339C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/559,544 US3960927A (en) 1975-03-18 1975-03-18 Olefinic derivatives of amino acids
US55954475 1975-03-18

Publications (3)

Publication Number Publication Date
DK31476A DK31476A (da) 1976-09-19
DK145339B DK145339B (da) 1982-11-01
DK145339C true DK145339C (da) 1983-03-21

Family

ID=24233995

Family Applications (1)

Application Number Title Priority Date Filing Date
DK31476A DK145339C (da) 1975-03-18 1976-01-27 Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf

Country Status (20)

Country Link
US (1) US3960927A (fr)
JP (1) JPS593988B2 (fr)
BE (1) BE839657A (fr)
CA (1) CA1077487A (fr)
CH (1) CH631696A5 (fr)
DE (1) DE2607620C2 (fr)
DK (1) DK145339C (fr)
ES (1) ES445659A1 (fr)
FR (1) FR2304329A1 (fr)
GB (1) GB1472525A (fr)
IE (1) IE42410B1 (fr)
IL (1) IL48912A (fr)
MX (1) MX4654E (fr)
NL (2) NL187161C (fr)
NO (1) NO146428C (fr)
NZ (1) NZ179834A (fr)
PH (1) PH12100A (fr)
PT (1) PT64761B (fr)
SE (1) SE442295B (fr)
ZA (1) ZA76411B (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039549A (en) * 1975-03-18 1977-08-02 Merrell Toraude Et Compagnie Olefinic derivatives of amino acids
US4041041A (en) * 1975-03-18 1977-08-09 Merrell Toraude Et Compagnie Acetylene derivatives of amino acids
CA1121375A (fr) * 1977-07-01 1982-04-06 Brian W. Metcalf Derives d'amines et d'acides amines
US4139563A (en) * 1977-07-01 1979-02-13 Merrell Toraude Et Compagnie α-ACETYLENIC DERIVATIVES OF AMINES
CA1157030A (fr) * 1977-07-01 1983-11-15 Brian W. Metcalf ACIDES AMINES .alpha.-VINYLIQUES
US4147873A (en) * 1977-07-01 1979-04-03 Merrell Toraude Et Compagnie α-Vinyl derivatives of α-amino acids
US4326071A (en) * 1977-09-28 1982-04-20 Merrell Toraude Et Compagnie Halomethyl derivatives of gamma-aminobutyric acid and related compounds
US4187316A (en) * 1978-01-12 1980-02-05 Merrell Toraude Et Compagnie Substituted 1,5-cyclohexadiene carboxylic acid derivatives
US4254284A (en) * 1978-01-30 1981-03-03 Merrell Toraude Et Compagnie Process for preparing 4-aminohex-5-ynoic acid
US4178463A (en) * 1978-01-30 1979-12-11 Merrell Toraude Et Compagnie Process for making 4-aminohex-5-enoic acid
US4880793A (en) * 1978-07-24 1989-11-14 Merck & Co., Inc. Combination of thienamycin-type antibiotics with dipeptidase inhibitors
US5147868A (en) * 1978-07-24 1992-09-15 Merck & Co., Inc. Thienamycin renal peptidase inhibitors
US4323704A (en) * 1979-06-25 1982-04-06 Merrell Toraude Et Compagnie αAcetylene and α-vinyl derivatives of amino acids
US4539208A (en) * 1980-09-17 1985-09-03 Merck & Co., Inc. Combination of thienamycin-type antibiotics with dipeptidase inhibitors
US4372974A (en) * 1980-06-25 1983-02-08 New York University Anticonvulsive compositions and method of treating convulsive disorders
GB2120244B (en) * 1982-05-17 1985-05-01 Merrell Toraude & Co Aminoalkadiene derivative
GB2133002B (en) * 1982-12-30 1986-01-29 Merrell Toraude & Co Process for preparing 4-amino-5-hexenoic acid
GB8311804D0 (en) * 1983-04-29 1983-06-02 Merrell Toraude & Co Treatment of seizure disorders and pharmaceutical compositions
US4668703A (en) * 1983-07-07 1987-05-26 Syntex (U.S.A.) Inc. γ-allenyl-γ-aminobutyric acids
ATE31407T1 (de) * 1983-07-07 1988-01-15 Syntex Inc Gamma-allenyl-gamma-aminobuttersaeuren.
US4661510A (en) * 1983-08-17 1987-04-28 Syntex (U.S.A.) Inc. α-allenic-α-amino acids as enzyme inhibitors
US4588825A (en) * 1983-10-11 1986-05-13 Merrell Dow Pharmaceuticals Inc. Intermediates for the synthesis of 4-amino-4,5-dihydro-2-furancarboxylic acid
US4632994A (en) * 1983-11-04 1986-12-30 Gruppo Lepetit S.P.A. Process for decomposing N-oxide derivatives producing 5-vinyl-2-pyrrolidones
JPS6137389U (ja) * 1984-08-09 1986-03-08 永大産業株式会社 家具用の戸
DE3536146A1 (de) * 1985-10-10 1987-04-16 Degussa Verfahren zur enantioselektiven herstellung von (alpha)-vinyl-(alpha)-aminocarbonsaeuren
US4806680A (en) * 1986-03-17 1989-02-21 Merck & Co., Inc. 3-halovinylglycine antibacterial agents
US4727062A (en) * 1986-03-17 1988-02-23 Merck & Co., Inc. 3-Halovinylglycine antibacterial agents
AU629419B2 (en) 1989-11-07 1992-10-01 Aventis Inc. Process for the production of vinyl-gaba
US5208345A (en) * 1990-12-17 1993-05-04 Merrell Dow Pharmaceuticals Inc. Process for the production of (S)-vinyl and allenyl gaba
AU644919B2 (en) * 1990-12-17 1993-12-23 Aventisub Ii Inc. Process for the production of (S)-vinyl and allenyl gaba
EP0546230A1 (fr) * 1991-12-10 1993-06-16 Merrell Dow Pharmaceuticals Inc. Nouveau procédé pour la préparation de l'acide 4-amino 5-hexénoique
US5705660A (en) * 1994-08-22 1998-01-06 Board Of Regents, University Of Nebraska-Lincoln Method for the synthesis of α-oxiranyl amino acids
US7098206B2 (en) * 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6998400B2 (en) * 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
AU2349999A (en) 1998-01-29 1999-08-16 Sepracor, Inc. Pharmacological uses of pure (+) -bupropion
JP2002501892A (ja) * 1998-01-29 2002-01-22 セプラコア インコーポレーテッド 光学的に純粋な（−）−ビュープロピオンの薬学的使用
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
US6855820B2 (en) 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6342496B1 (en) * 1999-03-01 2002-01-29 Sepracor Inc. Bupropion metabolites and methods of use
US6337328B1 (en) * 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
EE200300249A (et) 2000-11-30 2003-10-15 Pfizer Products Inc. GABA agonistide ja aldoosreduktaasi inhibiitoritekombinatsioon
PT1337271E (pt) 2000-11-30 2005-01-31 Pfizer Prod Inc Combinacao de agonistas de gaba e inibidores de sorbitol desidrogenase
WO2004100992A2 (fr) * 2003-05-16 2004-11-25 Pfizer Products Inc. Combinaisons therapeutiques d'antipsychotiques atypiques avec des modulateurs de l'acide 4-aminobutanoique et/ou des medicaments anticonvulsivants
ES2515092T3 (es) 2003-12-11 2014-10-29 Sunovion Pharmaceuticals Inc. Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión
JP2007537151A (ja) * 2004-01-29 2007-12-20 ファイザー・プロダクツ・インク γ−アミノ酪酸モジュレータと５−ＨＴ１Ｂ受容体アンタゴニストとの組合せ
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (fr) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
EP1942879A1 (fr) 2005-10-31 2008-07-16 Braincells, Inc. Modulation de la neurogenese dont la mediation est assuree par recepteur gaba
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2021000A2 (fr) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenèse par modulation de l'angiotensine
AU2007249435A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 HT receptor mediated neurogenesis
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
CA2679741A1 (fr) * 2007-03-15 2008-09-18 Sun Pharma Advanced Research Company Ltd. Nouveaux promedicaments
WO2010099217A1 (fr) 2009-02-25 2010-09-02 Braincells, Inc. Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine
EP2537827B1 (fr) 2011-06-24 2014-06-11 Targeon SAS Procédé pour la préparation d'acide 4-amino-5-hexénoïque du succinimide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2460708A (en) * 1946-03-22 1949-02-01 Merck & Co Inc Process for making acetamido dimethylacrylic acid
US2531595A (en) * 1949-06-09 1950-11-28 Sterling Drug Inc Preparation of alpha-acylamino-alpha-substituted-acetic acids
US2588969A (en) * 1949-11-26 1952-03-11 Eastman Kodak Co Certain acylamino-acrylates and-crotonates as insecticides
US3223729A (en) * 1962-06-06 1965-12-14 Sterling Drug Inc 3-allylhydantoic acid

Also Published As

Publication number Publication date
IE42410B1 (en) 1980-07-30
DE2607620A1 (de) 1976-09-30
ES445659A1 (es) 1977-06-01
IL48912A0 (en) 1976-03-31
ZA76411B (en) 1977-01-26
DK145339B (da) 1982-11-01
PT64761B (en) 1977-06-06
NO760234L (fr) 1976-09-21
US3960927A (en) 1976-06-01
JPS51125320A (en) 1976-11-01
CA1077487A (fr) 1980-05-13
DE2607620C2 (de) 1984-09-13
PT64761A (en) 1976-03-01
BE839657A (fr) 1976-07-16
NL7601116A (nl) 1976-09-21
SE442295B (sv) 1985-12-16
FR2304329A1 (fr) 1976-10-15
CH631696A5 (de) 1982-08-31
NL930125I2 (nl) 1997-08-01
IE42410L (en) 1976-09-18
JPS593988B2 (ja) 1984-01-27
NL187161C (nl) 1991-06-17
FR2304329B1 (fr) 1980-07-18
NO146428B (no) 1982-06-21
GB1472525A (en) 1977-05-04
NZ179834A (en) 1978-06-20
NL930125I1 (nl) 1993-11-01
SE7601205L (sv) 1976-09-19
NO146428C (no) 1982-09-29
MX4654E (es) 1982-07-19
PH12100A (en) 1978-11-02
NL187161B (nl) 1991-01-16
AU1071676A (en) 1977-08-11
DK31476A (da) 1976-09-19
IL48912A (en) 1980-09-16

Similar Documents

Publication Publication Date Title
DK145339C (da) Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf
DK145119C (da) Analogifremgangsmaade til fremstilling af phenolethere eller syreadditionssalte deraf
DK154939C (da) Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DK151331C (da) Analogifremgangsmaade til fremstilling af 5-pyridinyl-2(1h)-pyridinon-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK152495C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf
DK154654C (da) Analogifremgangsmaade til fremstilling af immunmodulerende 2-oe2-acylamino-2-desoxy-(d)-glucosyl-3-oaa-alkancarboxylsyrepeptid-derivater eller farmaceutisk acceptable salte deraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK149609C (da) Analogifremgangsmaade til fremstilling af hydroxyamino-alkan- eller -alkenphosphonsyrederivater eller estere eller salte deraf
DK151330C (da) Analogifremgangsmaade til fremstilling af aminoalkoholderivater eller farmaceutiske acceptable salte deraf
DK146538C (da) Analogifremgangsmaade til fremstilling af 7alfa-methoxycephalosporinderivater eller farmaceutisk acceptable salte deraf
DK157246C (da) Analogifremgangsmaade til fremstilling af n-acylamino-alfa-phenylacetamidocephalosporiner eller farmaceutisk acceptable salte heraf.
DK154950C (da) Analogifremgangsmaade til fremstilling af 1-(benzazolylalkyl)-piperidinderivater eller de farmaceutisk acceptable syreadditionssalte deraf
DK149230C (da) Analogifremgangsmaade til fremstilling af 5-benzoyl-6-hydroxy-indan-1-carboxylsyrederivater eller farmaceutisk acceptable salte deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK155670C (da) Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK149077C (da) Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK149841C (da) Analogifremgangsmaade til fremstilling af alfa-fluor-methyl-alfa-aminoalkansyrer eller farmaceutisk acceptable syreadditionssalte deraf
DK143105C (da) Analogifremgangsmaade til fremstilling af aminobenzocycloheptenderivater eller farmaceutisk acceptable additionssalte deraf
DK152208C (da) Analogifremgangsmaade til fremstilling af 2-phenylamino-phenyleddikesyreamider eller farmaceutisk acceptable salte deraf
DK143278C (da) Analogifremgangsmaade til fremstilling af n-(r-tetrahydrofurfuryl)-noroxymorphon eller syreadditionssalte deraf
DK155520C (da) Analogifremgangsmaade til fremstilling af aminosyrederivater eller fysiologisk acceptable salte deraf
DK144793C (da) Analogifremgangsmaade til fremstilling af dihydro- eller tetrahydroiminothiaziner eller farmaceutisk acceptable syreadditionssalte deraf
DK148019C (da) Analogifremgangsmaade til fremstilling af 2-pyridylaminobenzoesyrer eller farmaceutisk acceptable salte deraf

Legal Events

Date Code Title Description
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1993 00048, 930630

CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1993 00048, 930630

PUP Patent expired